You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 5, May 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Primary Cutaneous Non-T, Non-B CD4+, CD56+ Lymphoma

Reinhard Dummer, MD; Natascha Potoczna, MS; Andreas C. Häffner, MD; Dieter R. Zimmermann, PhD; Stefano Gilardi, MD; Günter Burg, MD

Arch Dermatol. 1996;132(5):550-553.


Abstract

Background
Cutaneous lymphomas are heterogeneous clonal lymphoproliferative disorders originating from B or T lymphocytes.

Observation
We describe a patient with a unique primary cutaneous lymphoma characterized by a bruiselike aspect of the skin lesions, a CD4+, CD43+, CD56+, CD2-, CD3-, CD8-, T-cell receptor-negative phenotype of the medium-sized to large lymphoid tumor cells and an undetermined genotype (T-cell receptor β and immunoglobulin heavy chain in germline configuration, no clonal T-cell receptor {gamma} population as detected after analysis with polymerase chain reaction combined with denaturing gradient gel electrophoresis) and fast relapse after radiotherapy.

Conclusions
This non-B, non-T cutaneous lymphoma cannot be classified by any current lymphoma classification. It seems to represent a new disease entity with peculiar clinical, histologic, and molecular features.

Arch Dermatol. 1996;132:550-553)



Author Affiliations

From the Departments of Dermatology (Drs Dummer, Häffner, Burg, and Ms Potoczna) and Pathology (Dr Zimmermann), University of Zürich (Switzerland) Medical School. Dr Gilardi is in private practice in Locarno, Switzerland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
Bekkenk et al.
Ann Oncol 2004;15:1097-1108.
ABSTRACT | FULL TEXT  

CD56+ Lymphoma With Skin Involvement: Clinicopathologic Features and Classification
Arch Dermatol 2004;140:427-436.
 

Clinical and biologic features of CD4+CD56+ malignancies
Feuillard et al.
Blood 2002;99:1556-1563.
ABSTRACT | FULL TEXT  

Junctional CD8+ Cutaneous Lymphomas With Nonaggressive Clinical Behavior: A CD8+ Variant of Mycosis Fungoides?
Dummer et al.
Arch Dermatol 2002;138:199-203.
ABSTRACT | FULL TEXT  

Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas
Kamarashev et al.
Am. J. Pathol. 2001;158:1593-1598.
ABSTRACT | FULL TEXT  

Primary Cutaneous Natural Killer/ T-Cell Lymphoma
Bastian et al.
Arch Dermatol 1998;134:109-111.
FULL TEXT  

Cutaneous Lymphomas Consist of a Spectrum of Nosologically Different Entities Including Mycosis Fungoides and Small Plaque Parapsoriasis
Burg et al.
Arch Dermatol 1996;132:567-572.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.